Impact of serum phosphate levels during CRRT on extubation failure and hospital mortality in mechanically ventilated ICU patients-A study based on the MIMIC-IV database.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40531977.
- Also identified by DOI 10.1371/journal.pone.0323939 and PMC identifier 12176230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Electrolyte imbalances, particularly phosphate depletion, are prevalent yet often underestimated complications in the Intensive Care Unit (ICU), notably among patients undergoing Continuous Renal Replacement Therapy (CRRT). Therefore, this study aims to examine the impact of serum phosphate levels during CRRT on the incidence of extubation failure and hospital mortality in mechanically ventilated patients. Patients subjected to both CRRT and mechanical ventilation were extracted from the MIMIC-IV database. Cox regression analysis was employed to identify the potential risk factors for the extubation failure and hospital mortality rates. Patients were categorized into three groups based on their minimum serum phosphate level (Phosphate_min) during CRRT. Kaplan-Meier survival analysis and Receiver Operating Characteristic (ROC) curves were employed to assess differences in the primary outcomes among these groups. Additionally, a restricted cubic spline curve was utilized to explore potential nonlinear relationships between Phosphate_min and the primary outcomes. The analysis included 816 ICU patients undergoing CRRT and mechanical ventilation. Cox regression analysis identified Phosphate_min as a significant risk factor for both extubation failure (HR 1.29; 95% CI 1.22-1.36, p < 0.001) and hospital mortality (HR 1.48; 95% CI 1.37-1.60, p < 0.001). ROC curve analysis indicated that a Phosphate_min > 4.5 mg/dL was a moderate predictor for both extubation failure and hospital mortality. Kaplan-Meier analysis revealed significantly higher risks of the primary outcomes in the group with Phosphate_min > 4.5 mg/dL compared to the lower phosphate groups (log-rank p < 0.001). Additionally, restricted cubic spline analysis showed a J-shaped relationship between Phosphate_min and both primary outcomes, with nadirs at approximately 1.60 mg/dL for extubation failure and 1.98 mg/dL for hospital mortality. Phosphate_min emerges as an independent risk factor for both extubation failure and hospital mortality. Maintaining serum phosphate levels within a therapeutic range may potentially mitigate these risks.
Medical subject headings
- Phosphates
- Hospital Mortality
- Respiration, Artificial
- Continuous Renal Replacement Therapy
- Airway Extubation